VitaNova Life Sciences (VNOV) EBIT Growth (3y) (2020 - 2026)
VitaNova Life Sciences (VNOV) EBIT Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 102.57 Bn | 97.41 Bn | 3.69 Bn | 6.24% |
| 2 | Cencora | 61.35 Bn | 58.53 Bn | 3.61 Bn | 18.68% |
| 3 | Cardinal Health | 54.15 Bn | 49.30 Bn | 2.56 Bn | 65.10% |
| 4 | Henry Schein | 10.05 Bn | 9.89 Bn | 1.10 Bn | -5.25% |
| 5 | Akso Health | 671.90 Mn | 671.70 Mn | - | - |
| 6 | Edap Tms | 154.62 Mn | 133.07 Mn | 7.34 Mn | -20.42% |
| 7 | Accendra Health | 90.69 Mn | 83.04 Mn | 263.41 Mn | -73.72% |
| 8 | 111 | 31.31 Mn | -27.44 Mn | 18.18 Mn | 3.19% |
| 9 | Cosmos Health | 13.28 Mn | 10.84 Mn | 1.51 Mn | -4.33% |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | -192.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -192.61% |
| Jan 31, 2026 | 66.97% |
| Oct 31, 2025 | 182.17% |
| Jul 31, 2025 | -158.14% |
| Apr 30, 2025 | 248.63% |
| Jan 31, 2025 | 65.04% |
| Oct 31, 2024 | 59.89% |
| Jul 31, 2024 | -63.00% |
| Apr 30, 2024 | 123.09% |
| Jan 31, 2024 | 59.42% |
| Oct 31, 2023 | 10.92% |
| Jul 31, 2023 | -29.18% |
| Apr 30, 2023 | 44.99% |
| Jan 31, 2023 | -38.72% |
| Oct 31, 2022 | 30.57% |
| Jul 31, 2022 | 28.21% |
| Apr 30, 2022 | -25.39% |
| Jan 31, 2022 | 38.56% |
| Oct 31, 2021 | -54.96% |
| Jul 31, 2021 | 12.82% |